Physician profile
David L Combs
NPI 1013968619
$463.45
in general payments reported to CMS, 2019-2025
15 companies · $21.35 in 2025
The $21.35 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.67 · 2020: $199 · 2021: $127 · 2022: $28.10 · 2023: $21.12 · 2024: $22.62 · 2025: $21.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.80 | 2020-2021 | |
| Eisai INC. | $39.36 | 2020-2021 | |
| Lilly USA, LLC | $32.93 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $29.75 | 2019-2021 | |
| Ibsa Pharma INC. | $29.34 | 2020 | |
| Abbvie INC. | $28.10 | 2022 | |
| Novo Nordisk INC | $23.42 | 2020-2021 | |
| Dexcom, INC. | $22.62 | 2024 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $21.35 | 2025 | Varithena Administration Pack |
| Philips North America LLC | $21.12 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $17.07 | 2021 | |
| Merck Sharp & Dohme LLC | $15.80 | 2020 | |
| Genentech USA, INC. | $15.65 | 2021 | |
| Gilead Sciences, INC. | $15.43 | 2019 | |
| Aytu Biopharma, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.